Aileron Therapeutics Stock Annual Yield
ALRNDelisted Stock | USD 2.11 0.15 7.65% |
Aileron Therapeutics fundamentals help investors to digest information that contributes to Aileron Therapeutics' financial success or failures. It also enables traders to predict the movement of Aileron Stock. The fundamental analysis module provides a way to measure Aileron Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aileron Therapeutics stock.
Aileron |
Aileron Therapeutics Company Annual Yield Analysis
Aileron Therapeutics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Aileron Therapeutics has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Aileron Fundamentals
Return On Equity | -0.44 | |||
Return On Asset | -0.26 | |||
Current Valuation | 28.45 M | |||
Shares Outstanding | 21.67 M | |||
Shares Owned By Insiders | 0.60 % | |||
Shares Owned By Institutions | 28.47 % | |||
Number Of Shares Shorted | 141.21 K | |||
Price To Earning | (0.31) X | |||
Price To Book | 0.91 X | |||
Gross Profit | (17.01 M) | |||
EBITDA | (15.61 M) | |||
Net Income | (15.73 M) | |||
Cash And Equivalents | 32.38 M | |||
Cash Per Share | 0.36 X | |||
Total Debt | 48 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 6.51 X | |||
Book Value Per Share | 1.41 X | |||
Cash Flow From Operations | (19.81 M) | |||
Short Ratio | 3.47 X | |||
Earnings Per Share | (2.88) X | |||
Target Price | 13.0 | |||
Number Of Employees | 15 | |||
Beta | 2.34 | |||
Market Capitalization | 45.72 M | |||
Total Asset | 106.01 M | |||
Retained Earnings | (288.52 M) | |||
Working Capital | 13.88 M | |||
Current Asset | 3.43 M | |||
Current Liabilities | 459 K | |||
Net Asset | 106.01 M |
About Aileron Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aileron Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aileron Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aileron Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aileron Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aileron Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Aileron Stock
0.9 | BA | Boeing Earnings Call This Week | PairCorr |
0.68 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.68 | AXP | American Express Earnings Call Today | PairCorr |
0.52 | DIS | Walt Disney | PairCorr |
0.51 | IBM | International Business Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Aileron Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aileron Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aileron Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aileron Therapeutics to buy it.
The correlation of Aileron Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aileron Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aileron Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aileron Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Aileron Stock
If you are still planning to invest in Aileron Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aileron Therapeutics' history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |